List of Tables
Table 1. Global Anti-amyloid-β Monoclonal Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-amyloid-β Monoclonal Antibodies Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-amyloid-β Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-amyloid-β Monoclonal Antibodies Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-amyloid-β Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-amyloid-β Monoclonal Antibodies Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-amyloid-β Monoclonal Antibodies Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-amyloid-β Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-amyloid-β Monoclonal Antibodies, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-amyloid-β Monoclonal Antibodies, Product Type & Application
Table 12. Global Key Manufacturers of Anti-amyloid-β Monoclonal Antibodies, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-amyloid-β Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-amyloid-β Monoclonal Antibodies as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-amyloid-β Monoclonal Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-amyloid-β Monoclonal Antibodies Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Region (2019-2024)
Table 19. Global Anti-amyloid-β Monoclonal Antibodies Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Region (2025-2030)
Table 21. Global Anti-amyloid-β Monoclonal Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-amyloid-β Monoclonal Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-amyloid-β Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-amyloid-β Monoclonal Antibodies Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-amyloid-β Monoclonal Antibodies Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-amyloid-β Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-amyloid-β Monoclonal Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-amyloid-β Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-amyloid-β Monoclonal Antibodies Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-amyloid-β Monoclonal Antibodies Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-amyloid-β Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-amyloid-β Monoclonal Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-amyloid-β Monoclonal Antibodies Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-amyloid-β Monoclonal Antibodies Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-amyloid-β Monoclonal Antibodies Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-amyloid-β Monoclonal Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-amyloid-β Monoclonal Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-amyloid-β Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-amyloid-β Monoclonal Antibodies Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-amyloid-β Monoclonal Antibodies Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-amyloid-β Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Anti-amyloid-β Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Anti-amyloid-β Monoclonal Antibodies Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Anti-amyloid-β Monoclonal Antibodies Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Anti-amyloid-β Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Anti-amyloid-β Monoclonal Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-amyloid-β Monoclonal Antibodies Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-amyloid-β Monoclonal Antibodies Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Type (2019-2024)
Table 53. Global Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Type (2025-2030)
Table 54. Global Anti-amyloid-β Monoclonal Antibodies Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-amyloid-β Monoclonal Antibodies Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-amyloid-β Monoclonal Antibodies Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-amyloid-β Monoclonal Antibodies Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-amyloid-β Monoclonal Antibodies Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-amyloid-β Monoclonal Antibodies Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Application (2019-2024)
Table 63. Global Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Application (2025-2030)
Table 64. Global Anti-amyloid-β Monoclonal Antibodies Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-amyloid-β Monoclonal Antibodies Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-amyloid-β Monoclonal Antibodies Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-amyloid-β Monoclonal Antibodies Price (US$/Unit) by Application (2025-2030)
Table 70. Eisai Company Information
Table 71. Eisai Description and Business Overview
Table 72. Eisai Anti-amyloid-β Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Eisai Anti-amyloid-β Monoclonal Antibodies Product
Table 74. Eisai Recent Developments/Updates
Table 75. Biogen Company Information
Table 76. Biogen Description and Business Overview
Table 77. Biogen Anti-amyloid-β Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Biogen Anti-amyloid-β Monoclonal Antibodies Product
Table 79. Biogen Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Anti-amyloid-β Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly Anti-amyloid-β Monoclonal Antibodies Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Anti-amyloid-β Monoclonal Antibodies Distributors List
Table 88. Anti-amyloid-β Monoclonal Antibodies Customers List
Table 89. Anti-amyloid-β Monoclonal Antibodies Market Trends
Table 90. Anti-amyloid-β Monoclonal Antibodies Market Drivers
Table 91. Anti-amyloid-β Monoclonal Antibodies Market Challenges
Table 92. Anti-amyloid-β Monoclonal Antibodies Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-amyloid-β Monoclonal Antibodies
Figure 2. Global Anti-amyloid-β Monoclonal Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-amyloid-β Monoclonal Antibodies Market Share by Type: 2023 & 2030
Figure 4. Lecanemab Product Picture
Figure 5. Donanemab Product Picture
Figure 6. Global Anti-amyloid-β Monoclonal Antibodies Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Anti-amyloid-β Monoclonal Antibodies Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Anti-amyloid-β Monoclonal Antibodies Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-amyloid-β Monoclonal Antibodies Market Size (2019-2030) & (US$ Million)
Figure 13. Global Anti-amyloid-β Monoclonal Antibodies Sales (2019-2030) & (K Units)
Figure 14. Global Anti-amyloid-β Monoclonal Antibodies Average Price (US$/Unit) & (2019-2030)
Figure 15. Anti-amyloid-β Monoclonal Antibodies Report Years Considered
Figure 16. Anti-amyloid-β Monoclonal Antibodies Sales Share by Manufacturers in 2023
Figure 17. Global Anti-amyloid-β Monoclonal Antibodies Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Anti-amyloid-β Monoclonal Antibodies Players: Market Share by Revenue in Anti-amyloid-β Monoclonal Antibodies in 2023
Figure 19. Anti-amyloid-β Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Anti-amyloid-β Monoclonal Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 22. North America Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Country (2019-2030)
Figure 23. United States Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 26. Europe Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Country (2019-2030)
Figure 27. Germany Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Region (2019-2030)
Figure 34. China Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 42. Mexico Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Anti-amyloid-β Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Anti-amyloid-β Monoclonal Antibodies Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Anti-amyloid-β Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Anti-amyloid-β Monoclonal Antibodies by Type (2019-2030)
Figure 52. Global Revenue Market Share of Anti-amyloid-β Monoclonal Antibodies by Type (2019-2030)
Figure 53. Global Anti-amyloid-β Monoclonal Antibodies Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Anti-amyloid-β Monoclonal Antibodies by Application (2019-2030)
Figure 55. Global Revenue Market Share of Anti-amyloid-β Monoclonal Antibodies by Application (2019-2030)
Figure 56. Global Anti-amyloid-β Monoclonal Antibodies Price (US$/Unit) by Application (2019-2030)
Figure 57. Anti-amyloid-β Monoclonal Antibodies Value Chain
Figure 58. Anti-amyloid-β Monoclonal Antibodies Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
